8 Analysts Have This to Say About Integra Lifesciences
Portfolio Pulse from Benzinga Insights
In the last 3 months, 8 analysts have provided 12-month price targets for Integra Lifesciences (NASDAQ:IART), with an average price target of $51.88, representing a 13.33% decrease from the previous average of $59.86.
June 08, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Integra Lifesciences (NASDAQ:IART) has an average 12-month price target of $51.88, a 13.33% decrease from the previous average of $59.86, based on 8 analysts' ratings.
The article provides an overview of the 12-month price targets given by 8 analysts for Integra Lifesciences (NASDAQ:IART). The average price target of $51.88 represents a 13.33% decrease from the previous average of $59.86. This information is relevant and important for investors in IART, as it provides insight into the analysts' opinions on the stock's future performance. However, the score remains neutral as the ratings are mixed, with 2 somewhat bullish, 4 indifferent, 1 somewhat bearish, and 1 bearish.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100